The Smart Inhalers Market is slated to grow at a gracious rate of 23.5%, reaching US$ 1 Bn by the year 2021-2031. With a value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, and AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward.
This updated analysis on the smart inhalers market by Persistence Market Research predicts the industry to surge ahead at a CAGR of 23.5% and attain a net worth of US$ 1 Bn by the end of the decade.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/26881
Respiratory disorders such as asthma and COPD have become more frequent over the past decade, and this trend is expected to be followed through this decade as well. With more instances of respiratory issues being recorded, demand for treatment and therapies for these disorders has also subsequently risen.
Adoption of smart inhalers is expected to rise as more healthcare professionals recommend them and their efficiency in drug delivery and drug tracking is realized. Increased medical adherence, reduced costs of treatment, improved and better results, and ability to track and maintain a record of clinical data are some of the factors that are expected to propel the adoption of smart inhalers.
Key manufacturers of smart inhalers are investing in reaching out to untapped markets and are focusing on increasing product awareness. They are also adopting organic as well as inorganic strategies to boost sales across regions.
In July 2019, Teva Pharmaceutical, a renowned pharmaceutical firm, announced that it has achieved FDA approval for its AirDuo Digihaler. The product is a sensor-enabled inhaler that sends usage data to a smartphone, and this information can also be shared with a medical provider.
In May 2021, RYAH Medtech Inc. signed an agreement with exclusive product distribution and software development rights to its French partner, Delled SAS, for the RYAH smart inhaler.
Company Profiles:
OPKO Health, Inc.
AstraZeneca plc
GlaxoSmithKline
Propeller Health
Aptar Pharma
Novartis AG
Boehringer Ingelheim
Teva Pharmaceuticals
H&T Presspart Manufacturing Ltd.
Sensirion AG
Cohero Health, Inc.
Others.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/26881
Key Takeaways from Market Study
The smart inhalers industry is predicted to expand at an impressive CAGR of 23.5% through 2031.
The market in China is expected to rise at the fastest pace through 2031.
Adoption of smart inhalers in North America is high and the market in this region accounts for a dominant share in the global landscape.
Lack of awareness in underdeveloped economies is a major restraining factor for market growth.
By 2031, the global smart inhalers market is predicted to be worth over US$ 1 Bn.
Increased medical adherence, rising proliferation of technology in the medical industry, and growing awareness about the benefits of smart inhalers are some of the factors that favor market growth potential.
To utilize the full revenue potential of the market, smart inhaler manufacturers would have to increase awareness and adoption of the product in developing regions, says a Persistence Market Research analyst.
Competitive Landscape
The global market for smart inhalers has been identified as a fairly fragmented space due to the presence of a high number of market participants.
Some of the key market players included in the report are GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc, Boehringer Ingelheim International GmbH, Aptar Pharma (AptarGroup, Inc.), Propeller Health, OPKO Health Inc., H&T Presspart Manufacturing Ltd., Sensirion AG, and Cohero Health Inc.
The above are identified as key suppliers of smart inhalers. These market participants are engaged in market expansion activities and are focusing on mergers and collaborations to develop a better product portfolio and drive their sales funnel.
More Valuable Insights on Offer
Persistence Market Research, a research and consulting firm, has published a new market research report on the global smart inhalers market that contains industry analysis of 20162020 and opportunity assessment for 20212031.
The report provides an in-depth analysis of the market through different segments, namely, product type, disease indication, distribution channel, and region. The report also provides supply and demand trends along with an overview of the parent market.-
Access Full Report@ https://www.persistencemarketresearch.com/checkout/26881
Key Questions Answered in the Smart Inhalers Market Report
How is the Smart Inhalers market expected to grow over the projected period?
What direction is the Smart Inhalers market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Smart Inhalers market in future?
What are the key market drivers in the Smart Inhalers market?
What are significant opportunities and improvement areas for Smart Inhalers manufacturers?
What are the key developments and trends taking over the Smart Inhalers market?
Which are the emerging countries that are expected to create significant growth opportunities in the Smart Inhalers market?
Latest Market Research Reports for You-
Iv Tubing Sets And Accessories Market –
According to Persistence Market Researchs analysis, the IV tubing sets and accessories market is projected to progress at a CAGR of close to 5% from 2021 to 2031.
The global medical spa market is expected to expand at an impressive CAGR of more than 15% over the next ten years, and be valued at over US$ 116 Bn by 2031-end.
Wheelchair And Components Market –
global wheelchair and components market is estimated to be valued at US$ 11 Bn in 2020, with the market expected to exhibit a CAGR of almost 4% over the forecast period (2020-2030).
Persistence Market Research expects the global cosmetic threads market to expand at around 7% CAGR through 2030.
About Us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Contact Us:
Persistence Market Research
Address 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. +1-646-568-7751
USA-Canada Toll-free +1 800-961-0353
Sales sales@persistencemarketresearch.com
